Acclinate is a trusted healthcare solutions provider integrating culture and technology to educate and engaging diverse individuals so they can make informed decisions about genomic research and clinical trial participation. We believe that diversifying genomic research and clinical trials to include more representation and diversity increases knowledge about health issues and makes a difference in personalized healthcare for all.
Beyond that, Acclinate and its founders, Del Smith and Tiffany Whitlow, have a passion to serve as a resource and supporter of diversity and inclusion through health, education, and entrepreneurship.